NCT04208373View on ClinicalTrials.gov

A Study to Assess the Effects of Itraconazole and Etravirine on JNJ-64417184 in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 20, 2019

Primary Completion Date

March 10, 2020

Study Completion Date

March 10, 2020

Conditions
Healthy
Interventions
DRUG

JNJ-64417184

JNJ 64417184 tablets will be administered orally.

DRUG

Itraconazole

Itraconazole capsules will be administered orally

DRUG

Etravirine

etravirine tables will be administered orally.

Trial Locations (1)

2060

SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg), Antwerp

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT04208373 - A Study to Assess the Effects of Itraconazole and Etravirine on JNJ-64417184 in Healthy Adult Participants | Biotech Hunter | Biotech Hunter